Qsam Biosciences Stock Revenue
Qsam Biosciences fundamentals help investors to digest information that contributes to Qsam Biosciences' financial success or failures. It also enables traders to predict the movement of Qsam OTC Stock. The fundamental analysis module provides a way to measure Qsam Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Qsam Biosciences otc stock.
Qsam |
Qsam Biosciences OTC Stock Revenue Analysis
Qsam Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Qsam Biosciences reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Qsam Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qsam Biosciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Qsam Biosciences could also be used in its relative valuation, which is a method of valuing Qsam Biosciences by comparing valuation metrics of similar companies.Qsam Biosciences is currently under evaluation in revenue category among its peers.
Qsam Fundamentals
| Return On Equity | -33.77 | |||
| Return On Asset | -2.38 | |||
| Current Valuation | 36.03 M | |||
| Shares Outstanding | 4.45 M | |||
| Shares Owned By Insiders | 52.36 % | |||
| Price To Book | 201.64 X | |||
| Price To Sales | 1.71 X | |||
| Gross Profit | 916.67 K | |||
| EBITDA | (3.94 M) | |||
| Net Income | (4.39 M) | |||
| Cash And Equivalents | 429.35 K | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 7.5 K | |||
| Debt To Equity | 2.08 % | |||
| Current Ratio | 0.23 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.85 M) | |||
| Earnings Per Share | (1.69) X | |||
| Beta | 1.81 | |||
| Market Capitalization | 73.79 B | |||
| Total Asset | 1.71 M | |||
| Retained Earnings | (40.16 M) | |||
| Working Capital | 672.35 K | |||
| Net Asset | 1.71 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |